Company: SCLXW
Filing Date: 2025-09-26
Form Type: 8-K
Source: 0001193125-25-220446
Chunk: 1

Company: Scilex Holding Co
Filing Date: 2025-09-26
Form: 8-K
Item: Item 2.01
Chunk 1
---
 the Company is filing certain updated risk factors disclosure applicable to its business for the purpose of supplementing and updating disclosures contained in the Company’s prior public filings, including those discussed under the heading “ Item 1A. Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 31, 2025 (as amended). The supplemental updated risk factors are filed herewith as Exhibit 99.2 and are incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Description                                                                                                                                                
   Number                                                                                                                                                                 
   10.1 #      Securities Purchase Agreement, dated September 23, 2025, by and among Scilex Holding Company, Scilex, Inc., Semnur Pharmaceuticals and Biconomy PTE. LTD.  
     99.1      Press release dated September 23, 2025.                                                                                                                    
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
     99.2      Supplemental Risk Factors.                                                                                                                                 
      104      Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).                                                      

# Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601. The Company agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                SCILEX HOLDING COMPANY                                             
                                By:                         /s/ Henry Ji                           
                                Name:                       Henry Ji                               
  Date: September 26, 2025      Title:                      Chief Executive Officer and President